Cantabio Pharmaceuticals

OverviewSuggest Edit

Cantabio Pharmaceuticals Inc. is a biotechnology company focusing on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson’s disease (PD), Alzheimer’s disease (AD) and other related neurodegenerative diseases. The company's strategy integrates a detailed therapeutic focus, target family biophysics, and drug discovery technology and expertise into an innovative drug discovery approach, which is identifying and developing small molecule pharmacological chaperones for clinical trials. In addition, the company is developing therapeutic proteins that can pass through the blood-brain barrier to supplement existing levels of proteins which display loss of function during disease conditions.
TypePublic
Founded2009
HQPalo Alto, US
Websitecantabio.com

Locations

Cantabio Pharmaceuticals is headquartered in
Palo Alto, United States

Location Map

Latest Updates

Employees (est.) (May 2017)11
Revenue (FY, 2014)$0
Share Price (Jan 2020)$25

Key People/Management at Cantabio Pharmaceuticals

Thomas Sawyer

Thomas Sawyer

Chief Financial Officer, Director
Max Zhu

Max Zhu

Director, Chief Business Development Officer
Johnny He

Johnny He

Director
Gergely Tóth

Gergely Tóth

Founder, Chief Executive Officer, Board Member
Show more

Cantabio Pharmaceuticals Office Locations

Cantabio Pharmaceuticals has offices in Palo Alto and Budapest
Palo Alto, US (HQ)
2225 E Bayshore Rd
Show all (2)

Cantabio Pharmaceuticals Financials and Metrics

Cantabio Pharmaceuticals Revenue

USD

Net income (Q3, 2019)

343.0k

EBIT (Q3, 2019)

(240.2k)

Market capitalization (8-Jan-2020)

562.5k

Closing stock price (8-Jan-2020)

25.0

Cash (31-Dec-2018)

283.4k
Cantabio Pharmaceuticals's current market capitalization is $562.5 k.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

Sales and marketing expense

General and administrative expense

585.0650.0221.0691.8k719.0k977.7k

R&D expense

149.2k350.3k371.0k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

Sales and marketing expense

General and administrative expense

66.0219.0223.085.05.4k373.0162.9k154.3k218.5k136.9k190.7k177.4k107.5k124.7k155.1k160.0k

R&D expense

2.3k112.7k69.1k86.9k97.2k98.9k58.5k111.2k79.0k80.2k
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

16.7k4.6k52.1k32.3k109.4k

Prepaid Expenses

12.5k1.2k

Current Assets

52.1k33.5k109.4k

Total Assets

30.2k4.6k52.1k33.5k109.4k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

3.4k5.3k12.1k8.0k100.9k195.6k12.6k10.8k5.0k51.2k26.8k185.2k21.5k283.4k

Prepaid Expenses

10.0k6.3k2.5k2.5k4.3k42.5k

Current Assets

2.5k4.3k100.9k195.6k12.6k10.8k5.0k51.2k26.8k185.2k21.5k325.9k

Total Assets

13.4k15.3k18.4k10.5k2.5k4.3k100.9k195.6k12.6k10.8k5.0k51.2k26.8k185.2k21.5k325.9k
USDY, 2018

Financial Leverage

-0.2 x
Show all financial metrics

Cantabio Pharmaceuticals Online and Social Media Presence

Embed Graph

Cantabio Pharmaceuticals Frequently Asked Questions

  • When was Cantabio Pharmaceuticals founded?

    Cantabio Pharmaceuticals was founded in 2009.

  • Who are Cantabio Pharmaceuticals key executives?

    Cantabio Pharmaceuticals's key executives are Thomas Sawyer, Max Zhu and Johnny He.

  • How many employees does Cantabio Pharmaceuticals have?

    Cantabio Pharmaceuticals has 11 employees.

  • Who are Cantabio Pharmaceuticals competitors?

    Competitors of Cantabio Pharmaceuticals include Cyclacel Pharmaceuticals, Roche and Rigel Pharmaceuticals.

  • Where is Cantabio Pharmaceuticals headquarters?

    Cantabio Pharmaceuticals headquarters is located at 2225 E Bayshore Rd, Palo Alto.

  • Where are Cantabio Pharmaceuticals offices?

    Cantabio Pharmaceuticals has offices in Palo Alto and Budapest.

  • How many offices does Cantabio Pharmaceuticals have?

    Cantabio Pharmaceuticals has 2 offices.